SENS Research Foundation
|Founder(s)||Aubrey de Grey, Jeff Hall, Michael Kope, Sarah Marr, Kevin Perrott|
|Headquarters||California, United States|
|Key people||Aubrey de Grey, Kevin Dewalt, Jeff Hall, Michael Kope, Barbara J. Logan, Sarah Marr, Kevin Perrott|
The SENS Research Foundation (Strategies for Engineered Negligible Senescence Research Foundation) is a 501(c)(3) non-profit organization co-founded by Michael Kope, Aubrey de Grey, Jeff Hall, Sarah Marr and Kevin Perrott, which is based in Mountain View, California, United States. Its activities include SENS-based research programs and public relations work for the acceptance of and interest in scientific rejuvenation research. Before the Foundation was launched in March 2009, the SENS research program was mainly pursued by the Methuselah Foundation, co-founded by Aubrey de Grey and David Gobel.
The foundation's stated goal is to "transform the way the world researches and treats age-related disease". It advocates the 'SENS' approach, which it describes as "the repair of living cells and extracellular material in situ", an approach it defines in equal contrast to both geriatric medicine's focus on specific diseases and infirmities, and biogerontology's focus on intervention in metabolic processes. It funds research and uses outreach and education in order to expedite the various regenerative medicine research programs that go together to make the SENS project.
In addition to research undertaken in-house at the Research Center in Mountain View, SRF has also taken part in and\or selectively funded extramural research at various other institutions, including but not limited to Yale University, Harvard University, Cambridge University, University of Texas, Rice University and University of Arizona.
SENS Research Foundation subdivide their efforts into seven research strands which correspond to seven categories of cellular damage which accumulate with age: accumulated side effects of metabolism which are eventually fatal. 
- Seven types of aging damage and SENS research strands:
- Cell loss and cell atrophy — Stem cells and tissue engineering 
- Nuclear [epi]mutations — WILT, short for "Whole-body Interdiction of Lengthening of Telomeres" 
- Mitochondrial mutations — Allotopic expression of 13 proteins 
- Death-resistant cells — Targeted removal 
- Extracellular crosslinks — AGE-breaking molecules and tissue engineering 
- Extracellular aggregates — Stimulating of the immune system to clear out the aggregates 
- Intracellular aggregates — Equipping the lysosome with enzymes capable of degrading the aggregates 
SENS Research Foundation has at least one project underway in each of its seven research themes.
 Outreach and Education
SRF reaches out to policy makers, potential donors, researchers and volunteers through conferences and public events, most notably the biennial SENS Conferences held at Queens' College, Cambridge, of which there have been five so far. They also host summer internships and produce online coursework for prospective students.
||This article is in a list format that may be better presented using prose. (July 2010)|
The founders of the SENS Research Foundation
- Michael Kope, Co-Founder : Chief Executive Officer
- Aubrey de Grey, Co-Founder : Chief Science Officer
- Kevin Perrott, Co-Founder : Board Member
- Jeff Hall, Co-Founder
- Sarah Marr, Co-Founder
Board of Directors:
- Barbara J. Logan : Chairperson
- Jonathan Cain : Board Member
- Michael Kope : Board Member
- Kevin Dewalt : Board Member
- Bill Liao : Board Member
- James O'Neill : Board Member
- Kevin Perrott, Co-Founder : Board Member
Other key staff members:
- Tanya Jones : Chief Operating Officer
- Matthew O’Connor, PhD : Senior Research Scientist
- Michael Rae : Science Writer
- Maria Entraigues : Global Outreach Coordinator
 Donors and volunteers
On September 16, 2006, Peter Thiel, co-founder and former CEO of the online payments system PayPal, announced that he is pledging $3.5 million to the Methuselah Foundation "to support scientific research into the alleviation and eventual reversal of the debilities caused by aging" (SENS research). Justin Bonomo, professional poker player, has pledged 5% of his tournament winnings for SENS research. Sam Harris, a prominent nonfiction writer and scientific skeptic, is a Methuselah Mouse Prize 300 member.
- "2011 Research report". September 18, 2006.
- de Grey, Aubrey; & Rae, Michael (September 2007). Ending Aging: The Rejuvenation Breakthroughs that Could Reverse Human Aging in Our Lifetime. New York, NY: St. Martin's Press. p. 416. ISBN 0-312-36706-6.
- "RepleniSENS". SENS Research Foundation. Retrieved 2010-12-17.
- "OncoSENS". SENS Research Foundation. Retrieved 2010-12-17.
- "MitoSENS". SENS Research Foundation. Retrieved 2010-12-17.
- "ApoptoSENS". SENS Research Foundation. Retrieved 2010-12-17.
- "GlycoSENS". SENS Research Foundation. Retrieved 2010-12-17.
- "AmyloSENS". SENS Research Foundation. Retrieved 2010-12-17.
- "LysoSENS". SENS Research Foundation. Retrieved 2010-12-17.
- "Summer Internships". January 15, 2013.
- "Board | SENS Research Foundation". sens.org. Retrieved 2013-01-30.
- "Executive Team | SENS Research Foundation". Sens.org. Retrieved 2013-01-30.
- "Staff | SENS Research Foundation". Sens.org. Retrieved 2013-01-30.
- Davidson, Keay (September 18, 2006). "BAY AREA — Entrepreneur backs research on anti-aging — Scientist says humans could live indefinitely". San Francisco Chronicle. Retrieved 2009-03-14.
- "Please Welcome the Newest Members of The Three Hundred". Methuselah Foundation Blog. Methuselah Foundation. January 18, 2007. Retrieved 2009-03-14.
- "Sam Harris is a 300 member?". Methuselah Foundation forums. Methuselah Foundation. March 11, 2009. Retrieved 2009-04-09.